Lawrence P. Guiheen, Director at ADMA BIOLOGICS, INC. (ADMA), bought 20,000 shares at $4.78 ($96K) on 2018-06-08, disclosed to the SEC on 2018-06-11.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| ADMA | SELL | 2024-09-11 | $166K | — | Filing → |
| ADMA | BUY | 2020-02-11 | $70K | — | Filing → |
| ADMA | BUY | 2019-05-21 | $100K | — | Filing → |